NCT04212338

Brief Summary

The objective of this study was to examine the effect of music intervention in the before-intravitreal injection (IVTI) and during-IVTI periods on patients' anxiety, the sensation of pain, physiological variables, satisfaction, and surgeon-patient cooperation. The study used a randomized controlled experimental design. The study was conducted with a total of three groups: two experimental (Before-IVTI (Group1) and During-IVTI music intervention group (Group 2)) and one control group. Each of the experimental and control groups consisted of 75 patients. The patients' anxiety was evaluated using the VAS anxiety scale, pain using the VAS pain scale; surgeon-patient cooperation using the Numeric Rating Scale; and patient satisfaction with a 5-point likert-type satisfaction scale.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
219

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 11, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 24, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 24, 2019

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 24, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 27, 2019

Completed
Last Updated

December 27, 2019

Status Verified

December 1, 2019

Enrollment Period

2 months

First QC Date

December 24, 2019

Last Update Submit

December 25, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale for Anxiety (VAS-A)

    VAS-A is a measurement tool, in which 0 represents feeling "no anxiety" while 10 represents "I feel extremely anxious".29 An increase in score indicates an increase in the anxiety experienced by the patient. This indicates that VAS-A is a reliable and accurate measurement tool despite its brevity. The VAS-A scale was applied to patients before, immediately after, and 15 minutes after the injection.

    1 day

Secondary Outcomes (1)

  • Visual Analog Scale for Pain (VAS)

    1 day

Other Outcomes (2)

  • Surgeon-patient cooperation

    1 day

  • Patient Satisfaction

    1 day

Study Arms (3)

study group 1

EXPERIMENTAL

Before intravitreal injection music intervention: These patients received the standard treatment and listened to music for a period of 15 minutes 30 minutes before the injection.

Other: Before intravitreal injection music intervention

study group 2

EXPERIMENTAL

During-intravitreal injection music intervention:These patients received the standard treatment and listened to music during the injection (approximately 5 minutes).

Other: during intravitreal injection music intervention

control group

NO INTERVENTION

The music intervention was not conducted with the patients in the control group. These patients received the standard treatment.

Interventions

The patients in the Before-IVTI group listened to music for a period of 15 minutes 30 minutes before the injection.

study group 1

The patients in the During-IVTI group listened to music during the injection (approximately 5 minutes).

study group 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The participants were patients aged 18 or above,
  • Who did not have a hearing/speech impairment, a mental problem or a diagnosed psychiatric disorder, who had not received a diagnosis of depression, who volunteered to participate in the study, and on whom elective IVTI was carried out, or who had undergone IVTI previously.

You may not qualify if:

  • The participants were patients aged under 18 years
  • Who had a hearing/speech impairment, a mental problem or a diagnosed psychiatric disorder, who had received a diagnosis of depression, who did not volunteered to participate in the study, and or who had not undergone IVTI previously.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Afyonkarahisar Health Science University

Afyonkarahisar, Centre, 03200, Turkey (Türkiye)

Location

Study Officials

  • Yeliz Ciğerci

    +90 272 444 0304

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

December 24, 2019

First Posted

December 27, 2019

Study Start

March 11, 2019

Primary Completion

May 24, 2019

Study Completion

May 24, 2019

Last Updated

December 27, 2019

Record last verified: 2019-12

Locations